Curaleaf (OTCMKTS:CURLF) Trading 6.2% Higher – What’s Next?

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) shares were up 6.2% on Monday . The stock traded as high as $10.20 and last traded at $10.0475. 105,761 shares changed hands during mid-day trading, a decline of 69% from the average session volume of 340,157 shares. The stock had previously closed at $9.46.

Wall Street Analyst Weigh In

Separately, Zacks Research lowered Curaleaf from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, June 3rd. Two investment analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Buy”.

Curaleaf Trading Down 1.5%

The company has a market capitalization of $2.31 billion, a P/E ratio of -25.39 and a beta of 1.51. The company has a quick ratio of 0.74, a current ratio of 1.56 and a debt-to-equity ratio of 1.05. The firm’s 50-day moving average price is $7.59 and its 200 day moving average price is $7.55.

Curaleaf (OTCMKTS:CURLF) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $0.27 EPS for the quarter, topping analysts’ consensus estimates of ($0.24) by $0.51. The firm had revenue of $324.23 million during the quarter, compared to analyst estimates of $316.62 million. Curaleaf had a negative return on equity of 8.11% and a negative net margin of 7.76%. As a group, equities research analysts predict that Curaleaf Holdings, Inc. will post -0.31 earnings per share for the current year.

About Curaleaf

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.